Purpose: There has been a focus on stewardship programmes to curb inappropriate antibiotic prescribing and reduce antimicrobial resistance. In-hospital, patient-level prescribing linked to indication is needed to support surveillance, evaluation of stewardship initiatives, as well as other antibiotic research. We evaluated whether a novel dataset linking hospital pharmacy records to Hospital Episode Statistics data can be used for antibiotic research.
| INTRODUCTION
Owing to a continued rise in resistance 1 and a slowing in the development of new antibiotics, 2 antimicrobial resistance (AMR) is currently poised to threaten the way we think about health care. A recognised risk factor for the emergence of resistance is excessive use of antibiotic treatment. 3 To tackle this issue, antimicrobial stewardship (AMS)
programmes are being implemented across the world to promote the effective use of antibiotics. [4] [5] [6] [7] In hospitals, appropriate and prudent treatment is particularly important, because the combination of vulnerable patients with high rates of co-morbidity, frequent antibiotic use, 2 and heavy dependence on broad-spectrum agents can create potent hotspots of AMR. 3 To facilitate effective and efficient AMR policies, further research on the uptake and impact of current hospital interventions is urgently needed. These efforts are hampered by the unavailability of longitudinal patient-level data due to a continued lack of widespread electronic prescribing in English secondary care. 8 As a result, only aggregated data on hospital prescribing exist on a national level. 9 While this aggregated information allows us to monitor overall trends in antibiotic usage, it prevents detailed enquiry into the association between indication and prescribing. Any impact specifically
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• Available from January 2010, HTI for the first time allows to analyse associations between diagnoses and hospital dispensing for individual patients in a relatively large number of NHS hospitals.
• • Linkage of antibiotic dispenses was found to vary with individual antibiotic and ward settings. Capture of dispensing was good for specific antibiotics, but low linkage of highly used treatments prevents HTI from being used for widespread antibiotic surveillance.
• Principles and findings may be generalised to other drug classes. For each drug of interest, the proportion of dispenses captured should be taken into account when designing future studies using HTI.
depends largely on the extent to which similar issues prevent HTI from accurately capturing antibiotic dispensing.
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Aggregated reference levels of antibiotic dispensing in HTI hospitals were taken from the Hospital Pharmacy Audit (HPA) database, which has been used for antibiotic surveillance by Public Health England. 9 Analogous to HTI, HPA is curated by QuintilesIMS and collected from hospital pharmacy systems, covering 99% of hospital beds in England. 12 However, unlike HTI, it does not contain patient specific information and is not, therefore, subject to data linkage. As a result, HPA includes bulk dispensing towards excluded in HTI, allowing for it to be used as a measure of total hospital dispensing.
| Study design
We conducted a retrospective cross-sectional study evaluating the proportion of antibiotic treatment that could be linked to a patient in All analyses were carried out using R software version 3.3.1 for Windows. 15 
| RESULTS
On average, 27.6% (CI: 27.4%-27.8%) of all antibiotics dispensed in hospitals contributing to HTI could be linked to an individual patient (Table 1 ). The general strength of linkage was high, with more than 85% of the linkage based on NHS number and 1 or more additional identifiers (see Supplement Table 1 ).
The proportion of packs linked to a patient depended on the form of the drug, the antibiotic agent, and the type of ward. Respiratory medicine and geriatrics had an above average linkage of 48.3%
(47.2%-49.8%) and 39.6% (CI: 38.9%-40.6%), respectively (Table 1) .
Emergency departments had much lower linkage of antibiotics, with Consequently, no individual patient files could be revisited, and records were treated as correctly linked where linkage was observed.
False linkage could not be investigated in this study. If the linkage algorithm falsely mapped dispenses and patients in a large proportion of cases, the findings in this study would overestimate true linkage.
This study has highlighted some limitations, which must be taken into account for antibiotic research using HTI as a data source. Further evaluation is needed on HTI for other therapeutic agents with particular emphasis on the role of ward stock. Papers looking into the validity of prescribing databases in primary care in England generally found a high conformity of the quantity of drugs recorded when compared with external sources. 16, 17 High coverage of drugs was also found for a secondary care database in the Taiwanese insurance-based health care system. 18 A study specifically investigating antibiotic prescribing in a Dutch secondary care database was able to obtain treatment for all patients with community-acquired pneumonia, although no validation of the obtained information was performed. 19 The comparably low linkage found for some antibiotics in this study likely reflects a high use of ward stock dispensing for antibiotic treatment in English hospitals 20 and a current inability to capture this dispensing. This conclusion is supported by findings on determining factors for linkage of dispensed drugs. Linkage was lowest across settings in which antibiotic usage tended to be either common or urgent, as is the case in A&E and intensive care. These situations potentially favour a higher utilisation of ward stock because of time constraints and efficiency gains. Linkage was generally higher for drugs like carbapenems and quinolones, which are used more cautiously and have been subject to increased stewardship measures over the last 15 years. 21 Yet, the high levels of linkage in geriatrics and respiratory medicine, as compared with general medicine, cannot be fully explained by these differences.
Although HTI in its current form does not seem to reflect a true picture of general antibiotic dispensing in secondary care, therefore preventing it from being used for widespread antibiotic surveillance, it has value for specific antibiotic research related to individual agents in specific ward settings, and may be used for broader studies where the missing drug usage can be estimated. There remains a pressing need for comprehensive and complete data to evaluate the intended and unintended impacts of AMS programmes in hospitals. However, although hospitals are clearly setting the course for e-prescribing, 22 full adoption and availability for secondary use might still take years. For now, linking HES to pharmacy data provides a potential mechanism to investigate some patient-level drug usage across NHS hospitals. We have shown that this is already possible for a number of antibiotics, in particular in medical settings that rely less on ward stocks. Using hospital identifiers within HTI to identify sites with above-average linkage could be used to further improve coverage and to enable the analysis of more common antibiotics in HTI. Finally, reducing the reliance on ward stock in hospitals in the panel might be a way to continue increasing this linkage. The unexpected large differences in linkage rates between closely related wards, seen for example in general medicine and geriatrics, suggest that it is feasible to do so. Further research will be needed to understand and learn from the systematic differences in these ward level processes, the results of which may aid in elevating the status of antibiotics from drugs used in everyday medicine to a limited resource that requires prudent management. 
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